Skip to content
What
Why
Who
More
Menu
What
Why
Who
More
Category:
News Coverage
Unlock the potential of complex human liver data
UK startups are built on immigrant talent, the UK will fail if it forgets this
Future of liver drugs – better AI or better data?
Ochre Bio: fully human, super speedy liver drug development
Exploring liver disease therapies
Ochre Bio with CEO/Co-founder Jack O’Meara and liver expert Dr Scott Friedman, Mount Sinai
Revolutionising Liver Transplants: Can Phenotyping Drive Biotech Transformation in Healthcare?
Business of Biotech with Ochre Bio’s Quin Wills, M.D., PH.D
Ochre Bio CEO named on Forbes 30 Under 30 Europe
18 European techbio startups to watch — according to investors
←
older
Join our Mailing List
Home
News
Careers
Contact Us
Login
Facebook-f
Twitter